JBPHF
Price
$0.29
Change
-$0.07 (-19.44%)
Updated
Feb 20 closing price
LXRX
Price
$0.71
Change
-$0.01 (-1.39%)
Updated
Dec 20, 04:59 PM (EDT)
80 days until earnings call
Ad is loading...

JBPHF vs LXRX

Header iconJBPHF vs LXRX Comparison
Open Charts JBPHF vs LXRXBanner chart's image
Jacobio Pharmaceuticals Group
Price$0.29
Change-$0.07 (-19.44%)
Volume$5K
CapitalizationN/A
Lexicon Pharmaceuticals
Price$0.71
Change-$0.01 (-1.39%)
Volume$43.28K
CapitalizationN/A
JBPHF vs LXRX Comparison Chart
Loading...
LXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
JBPHF vs. LXRX commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JBPHF is a Buy and LXRX is a Hold.

COMPARISON
Comparison
Dec 23, 2024
Stock price -- (JBPHF: $0.29 vs. LXRX: $0.71)
Brand notoriety: JBPHF and LXRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: JBPHF: 100% vs. LXRX: 154%
Market capitalization -- JBPHF: $130.96M vs. LXRX: $258.36M
JBPHF [@Biotechnology] is valued at $130.96M. LXRX’s [@Biotechnology] market capitalization is $258.36M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

JBPHF’s FA Score shows that 1 FA rating(s) are green whileLXRX’s FA Score has 1 green FA rating(s).

  • JBPHF’s FA Score: 1 green, 4 red.
  • LXRX’s FA Score: 1 green, 4 red.
According to our system of comparison, LXRX is a better buy in the long-term than JBPHF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LXRX’s TA Score shows that 5 TA indicator(s) are bullish.

  • LXRX’s TA Score: 5 bullish, 2 bearish.

Price Growth

JBPHF (@Biotechnology) experienced а 0.00% price change this week, while LXRX (@Biotechnology) price change was -11.80% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.20%. For the same industry, the average monthly price growth was -1.27%, and the average quarterly price growth was +2.17%.

Reported Earning Dates

LXRX is expected to report earnings on Mar 12, 2025.

Industries' Descriptions

@Biotechnology (-2.20% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LXRX($258M) has a higher market cap than JBPHF($131M). JBPHF YTD gains are higher at: -19.089 vs. LXRX (-53.288).
JBPHFLXRXJBPHF / LXRX
Capitalization131M258M51%
EBITDAN/A-198.7M-
Gain YTD-19.089-53.28836%
P/E RatioN/AN/A-
RevenueN/A5.23M-
Total CashN/A258M-
Total DebtN/A101M-
FUNDAMENTALS RATINGS
LXRX: Fundamental Ratings
LXRX
OUTLOOK RATING
1..100
55
VALUATION
overvalued / fair valued / undervalued
1..100
59
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
93
P/E GROWTH RATING
1..100
24
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
JBPHFLXRX
RSI
ODDS (%)
N/A
Bullish Trend 3 days ago
82%
Stochastic
ODDS (%)
N/A
Bullish Trend 3 days ago
82%
Momentum
ODDS (%)
N/A
Bullish Trend 3 days ago
77%
MACD
ODDS (%)
N/A
Bullish Trend 3 days ago
87%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
12%
Bearish Trend 3 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
9%
Bearish Trend 3 days ago
89%
Advances
ODDS (%)
N/A
Bullish Trend 14 days ago
81%
Declines
ODDS (%)
N/A
Bearish Trend 5 days ago
87%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Ad is loading...
LXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SVFCX75.711.06
+1.42%
Smead Value C
ALMAX14.050.15
+1.08%
Alger Weatherbie Specialized Growth A
QLSCX27.080.25
+0.93%
Federated Hermes MDT Small Cap Core R6
GMVRX16.280.14
+0.87%
Goldman Sachs Small/Mid Cap Value R
DCXAX8.800.07
+0.80%
Catalyst/Millburn Dynamic Cmdty Stgy A

JBPHF and

Correlation & Price change

A.I.dvisor indicates that over the last year, JBPHF has been closely correlated with RAPT. These tickers have moved in lockstep 79% of the time. This A.I.-generated data suggests there is a high statistical probability that if JBPHF jumps, then RAPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JBPHF
1D Price
Change %
JBPHF100%
N/A
RAPT - JBPHF
79%
Closely correlated
+2.18%
AXSM - JBPHF
32%
Poorly correlated
+1.10%
PYPD - JBPHF
23%
Poorly correlated
-8.00%
FRTX - JBPHF
22%
Poorly correlated
-0.34%
LXRX - JBPHF
21%
Poorly correlated
-1.23%
More

LXRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, LXRX has been loosely correlated with EPIX. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if LXRX jumps, then EPIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LXRX
1D Price
Change %
LXRX100%
-1.23%
EPIX - LXRX
44%
Loosely correlated
N/A
FRTX - LXRX
41%
Loosely correlated
-0.34%
NTLA - LXRX
37%
Loosely correlated
+0.83%
BEAM - LXRX
37%
Loosely correlated
+8.04%
SPRO - LXRX
37%
Loosely correlated
-4.30%
More